1-2 of 2
Anne M. Schultheis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MET Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the Lung

Free
Hans-Ulrich Schildhaus, Anne M. Schultheis, Josef Rüschoff, Elke Binot, Sabine Merkelbach-Bruse, Jana Fassunke, Wolfgang Schulte, Yon-Dschun Ko, Andreas Schlesinger, Marc Bos, Masyar Gardizi, Walburga Engel-Riedel, Michael Brockmann, Monika Serke, Ulrich Gerigk, Khosro Hekmat, Konrad F. Frank, Marcel Reiser, Holger Schulz, Stefan Krüger, Erich Stoelben, Thomas Zander, Jürgen Wolf, Reinhard Buettner
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (4): 907–915.
https://doi.org/10.1158/1078-0432.CCR-14-0450
Published: 16 February 2015
View articletitled, MET Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the Lung
Open the PDF for MET Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the Lung in another window
Journal Articles

Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab

Free
Anne M. Schultheis, Georg Lurje, Katrin E. Rhodes, Wu Zhang, Dongyun Yang, Agustin A. Garcia, Robert Morgan, David Gandara, Sidney Scudder, Amit Oza, Hal Hirte, Gini Fleming, Lynda Roman, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (22): 7554–7563.
https://doi.org/10.1158/1078-0432.CCR-08-0351
Published: 14 November 2008
View articletitled, Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab
Open the PDF for Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab in another window
Includes: Supplementary data